Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meneghini

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Neuroepidemiology|October 31, 2001
Door-to-door prevalence survey of epilepsy in three Sicilian municipalitiesW A Rocca, G Savettieri, D W Anderson, et al.
Neurology|June 1, 1993
Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) GroupG Savettieri, W A Rocca, G Salemi, et al.
Acta Neurologica Scandinavica|February 1, 1996
Prevalence of cervical spondylotic radiculopathy: a door-to-door survey in a Sicilian municipalityG Salemi, G Savettieri, F Meneghini, et al.
Neurology|October 1, 1992
Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) GroupL Morgante, W A Rocca, A E Di Rosa, et al.
Archives of Neurology|April 18, 2000
Parkinson disease survival: a population-based studyL Morgante, G Salemi, F Meneghini, et al.
Clinical Therapeutics|April 28, 2004
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trialAndrew J Lewin, Mark S Kipnes, Luigi F Meneghini, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assayP Ferroni, D Della-Morte, A Pileggi, et al.
Diabetes, Obesity & Metabolism|February 16, 2019
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world settingLuigi F Meneghini, Didac Mauricio, Emanuela Orsi, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE studyMarconi Abreu, Anna Tumyan, Ahmed Elhassan, et al.
Diabetes Care|January 29, 2011
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineKåre I Birkeland, Philip D Home, Ulrich Wendisch, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Neuroepidemiology|October 31, 2001
Door-to-door prevalence survey of epilepsy in three Sicilian municipalitiesW A Rocca, G Savettieri, D W Anderson, et al.
Neurology|June 1, 1993
Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) GroupG Savettieri, W A Rocca, G Salemi, et al.
Acta Neurologica Scandinavica|February 1, 1996
Prevalence of cervical spondylotic radiculopathy: a door-to-door survey in a Sicilian municipalityG Salemi, G Savettieri, F Meneghini, et al.
Neurology|October 1, 1992
Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) GroupL Morgante, W A Rocca, A E Di Rosa, et al.
Archives of Neurology|April 18, 2000
Parkinson disease survival: a population-based studyL Morgante, G Salemi, F Meneghini, et al.
Clinical Therapeutics|April 28, 2004
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trialAndrew J Lewin, Mark S Kipnes, Luigi F Meneghini, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assayP Ferroni, D Della-Morte, A Pileggi, et al.
Diabetes, Obesity & Metabolism|February 16, 2019
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world settingLuigi F Meneghini, Didac Mauricio, Emanuela Orsi, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE studyMarconi Abreu, Anna Tumyan, Ahmed Elhassan, et al.
Diabetes Care|January 29, 2011
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineKåre I Birkeland, Philip D Home, Ulrich Wendisch, et al.
Pageof 9